August 15, 2012 — Mission Search Corp., a Tampa, Fla.-based healthcare search and staffing organization, announced it has joined with Sensus Healthcare to provide commissioning services to Sensus’ clientele.

Sensus Healthcare is taking new aim by focusing on the design, manufacture and marketing of products and services that incorporate proprietary mobile X-ray technology for cost-effective, noninvasive treatment of non-melanoma skin cancers. The company’s SRT-100 meets the safety requirements set by the U.S. Food and Drug Administration (FDA), UL and ISO/CE mark certification.

Based in Boca Raton, Fla., Sensus Healthcare employs best-practice standard operational procedures to ensure quality control, high-grade customer support, optimized success in field operations and product reliability.

“We are pleased to partner with Sensus Healthcare to provide medical physics commissioning services for their superficial radiation therapy (SRT) systems and ultimately assisting Sensus as it brings non-melanoma skin cancer treatment to more patients in more settings,” said John Astrab, president and CEO of Mission Search Corp.

Added Joe Sardano, president and CEO of Sensus Healthcare: “We are excited to be partnering with the Mission Search team. We both share the same values when it comes to customer service and satisfaction. We are very much looking forward to growing our business with another great partner as the need for SRT continues to evolve.”

For more information: www.sensushealthcare.com, www.missionsearch.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Artificial Intelligence

June 27, 2024 — The American College of Radiology (ACR) launched the ACR Recognized Center for Healthcare-AI (ARCH-AI) ...

Time June 27, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
Subscribe Now